These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23685934)

  • 1. Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.
    Clark SW; Taylor J; Wang DL; Abramson JS; Batchelor TT
    Neurology; 2013 Jul; 81(1):93-4. PubMed ID: 23685934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
    Rivoirard R; Falk AT; Chargari C; Guy JB; Mery B; Nuti C; Peoc'h M; Forest F; Garin C; Adjabi A; Hoarau D; Kawaye S; Almokhles H; Fournel P; Magné N
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):486-7. PubMed ID: 25963856
    [No Abstract]   [Full Text] [Related]  

  • 3. Glioblastoma: If this is the "Temozolomide Era" Where is the Evidence?
    Perry JR
    Can J Neurol Sci; 2014 May; 41(3):301-2. PubMed ID: 24718814
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
    Clarke JL; Iwamoto FM; Sul J; Panageas K; Lassman AB; DeAngelis LM; Hormigo A; Nolan CP; Gavrilovic I; Karimi S; Abrey LE
    J Clin Oncol; 2009 Aug; 27(23):3861-7. PubMed ID: 19506159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide in glioblastoma multiforme of the elderly.
    Brandes AA; Vastola F; Basso U; Pasetto LM; Ermani M; Berti F; Rotilio A; Amistà P; Scienza R; Monfardini S
    Tumori; 2002; 88(1 Suppl 1):S69-70. PubMed ID: 11989929
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
    Tan CW; See SJ; Tham CK; Ang AL
    Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
    [No Abstract]   [Full Text] [Related]  

  • 8. Going past the data for temozolomide.
    Villano JL; Letarte N; Bressler LR
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme.
    Roldán Urgoiti GB; Singh AD; Easaw JC
    J Neurooncol; 2012 May; 108(1):173-7. PubMed ID: 22382781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant viral and bacterial encephalitis after temozolomide for glioblastoma.
    Tsai JP; Petrescu N; Mason WP; Casaubon LK
    Can J Neurol Sci; 2014 Jan; 41(1):84-5. PubMed ID: 24384343
    [No Abstract]   [Full Text] [Related]  

  • 11. Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
    Nagasawa DT; Chow F; Yew A; Kim W; Cremer N; Yang I
    Neurosurg Clin N Am; 2012 Apr; 23(2):307-22, ix. PubMed ID: 22440874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma.
    Chamberlain MC; Chalmers L
    J Neurooncol; 2007 Apr; 82(2):207-9. PubMed ID: 17019532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NICE verdict on Temozolomide: where next?
    Brada M
    Br J Cancer; 2002 Feb; 86(4):499-500. PubMed ID: 11870526
    [No Abstract]   [Full Text] [Related]  

  • 14. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 15. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.
    Chinot OL; Barrie M; Frauger E; Dufour H; Figarella-Branger D; Palmari J; Braguer D; Hoang-Xuan K; Moktari K; Peragut JC; Martin PM; Grisoli F
    Cancer; 2004 May; 100(10):2208-14. PubMed ID: 15139066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for cancer management: how can temozolomide carrier modifications improve its delivery?
    Sharma S; Italiya K; Mittal A; Chitkara D
    Ther Deliv; 2017 Jul; 8(7):475-477. PubMed ID: 28633588
    [No Abstract]   [Full Text] [Related]  

  • 18. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

  • 19. Temozolomide. A new option for high-grade astrocytomas.
    Schwenka J; Ignoffo RJ
    Cancer Pract; 2000; 8(6):311-3. PubMed ID: 11898150
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant temozolomide: how long and how much?
    Franceschi E; Tosoni A; Brandes AA
    Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.